Market Analysis - Tissue Science Congress 2017
Tissue Engineering is a process involving in-vitro development of tissues or organs. It is done to replace or support the function of defective or injured body part. Tissue engineering involves the application of biology and engineering for innovation of tissue substitutes that can maintain, restore and improve the function of ruptured human tissue. Products developed by this procedure are efficient and durable. Tissue engineering is gaining its popularity in various areas such as burn treatment or wound care, neurology products, orthopaedics, urological products and others. On the basis of type of material used, tissue engineering and regeneration market can be segmented into synthetic, genetically modified and biological materials. In terms of technology, tissue engineering and regeneration market can be segmented into immunoisolation technology, cell culture technology and stem cell technology.
On the basis of its applications, orthopedic and dermal sections have the largest market in tissue engineering and regeneration market. North America dominates the global market for tissue engineering and regeneration due to large number of aging people and increasing desire for such surgeries in the region. Europe is expected to experience less growth rate as compared to Asia. This is due to more stringent laws and regulations present in the region. Asia is expected to experience high growth rate in global tissue engineering and regeneration market. Some of the key driving forces for growth of tissue engineering and regeneration market in emerging countries are increasing pool of patients and increasing awareness in these regions.
Rising cost of organ transplantation and increasing medical applications of 3D printing in tissue and organ regeneration are driving the global tissue engineering and regeneration market. In addition, this technology is gaining popularity due to its efficient products and reduced rejection rates. Varied applications of this technology, for instance, its wound care followed by orthopedics applications has been driving this market at a high growth rate. Dental and neurologic applications are also expected to drive tissue engineering and regeneration market in near future. Globally, number of regeneration surgeries performed is increasing every year. According to Clear point Medical, which is involved in designing, manufacturing and distribution of compression wear, in 2013, in the U.S., number of reconstruction procedures performed increased by 2% from that in year 2012 and reached a number of about 5.6 million. However, due to slow development, high costs involved in procedure and increasing biological complexity of tissue engineering and regeneration procedures, the global tissue engineering and regeneration market is expected to impede.
Statistics which shows growth of Tissue Engineering and Regenerative Medicine:
Recent developments in the field of regeneration surgeries, particularly stem cell research, is expected to offer new opportunities for global tissue engineering and regeneration market. Big companies dealing in the market have been involved in partnerships, mergers and acquisitions with smaller companies. This is one the major trends observed in the global tissue engineering and regeneration market. In addition, companies are focusing on approval and patents for their products.
USA: Regenerative medicines market by therapy (cell therapy, gene therapy, immunotherapy, tissue engineering), region - global forecast to 2021, the global regenerative medicines market size is expected to reach USD 49.41 billion by 2021,. North America contributed the largest share in the global regenerative medicines market, and was dominated largely by the U.S.
Europe: The global tissue engineering and regeneration market reached $17 billion in 2013. This market is expected to grow to nearly $20.8 billion in 2014 and $56.9 billion in 2019, Today, there are 640 privately held and publicly traded companies in Europe, Japan, and the U.S.
Middle East: Middle East and Africa regenerative medicines market is expected to reach USD 5.75 billion by 2021 from USD 2.03 billion in 2016, growing at a CAGR of 23.15% during the forecast period 2016-2021. Regenerative medicines repair, replace or regenerate human cells, tissues, or organs affected due to injury, disease, aging processes, congenital defects, and damage due to trauma.
Asia Pacific: Asia-Pacific regenerative medicines market is expected to reach USD 10.71 billion by 2021 from USD 3.01 billion in 2016, growing at a CAGR of 28.90% during the forecast period 2016-2021. cell-based products segment is estimated to account for larger share of Asia-Pacific regenerative medicines market by product in 2016
Tissue Engineering Market, By Application, 2012 - 2022 (USD Million)
Conference LLC invites all the participants from all over the world to attend “8th International Conference on Tissue Science and Regenerative Medicine” during September 11-12, 2017 in Singapore City, Singapore which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.
Tissue Science and Regenerative Medicine 2017 on behalf of its organizing Committee welcomes all the stem cell technologists, researchers, industrialists, young scientists as well as student and corporate delegates to participate and to have a great experience. The theme of the conference is based on “Explore and Exploit the Novel Techniques to Repair, Restore and Regenerate”. International symposiums, B2B meetings, international workshops will also be organized to discuss the specific topics in the field of Stem cell technology during the conference. We also welcome International Exhibitions form corporate sectors to showcase the recent advancements in the tools and techniques.